ZA200806138B - Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same - Google Patents

Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same

Info

Publication number
ZA200806138B
ZA200806138B ZA200806138A ZA200806138A ZA200806138B ZA 200806138 B ZA200806138 B ZA 200806138B ZA 200806138 A ZA200806138 A ZA 200806138A ZA 200806138 A ZA200806138 A ZA 200806138A ZA 200806138 B ZA200806138 B ZA 200806138B
Authority
ZA
South Africa
Prior art keywords
tablet
melting point
active ingredient
same
oral administration
Prior art date
Application number
ZA200806138A
Other languages
English (en)
Inventor
Woo Jong Soo
Kim Sang Wook
Yi Hong Gi
Ryu Jae Kuk
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of ZA200806138B publication Critical patent/ZA200806138B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200806138A 2005-12-16 2006-12-18 Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same ZA200806138B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20050124386 2005-12-16

Publications (1)

Publication Number Publication Date
ZA200806138B true ZA200806138B (en) 2009-11-25

Family

ID=38163142

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806138A ZA200806138B (en) 2005-12-16 2006-12-18 Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same

Country Status (15)

Country Link
US (1) US20080292702A1 (fr)
EP (1) EP1968542B1 (fr)
JP (1) JP2009519326A (fr)
CN (1) CN101330904B (fr)
AU (1) AU2006325658B2 (fr)
BR (1) BRPI0619868A8 (fr)
CA (1) CA2633266C (fr)
ES (1) ES2429097T3 (fr)
HK (1) HK1126671A1 (fr)
IL (1) IL191804A0 (fr)
NO (1) NO339674B1 (fr)
NZ (1) NZ569813A (fr)
RU (1) RU2403013C2 (fr)
WO (1) WO2007069874A1 (fr)
ZA (1) ZA200806138B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004272111A1 (en) 2003-09-11 2005-03-24 Xenoport, Inc. Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
KR101067224B1 (ko) * 2008-07-22 2011-09-22 한국콜마 주식회사 이부프로펜 함유 서방출성 시럽제 및 그의 제조방법
KR101005391B1 (ko) * 2008-07-22 2010-12-30 한국콜마 주식회사 덱시부프로펜 함유 서방출성 시럽제 및 그의 제조방법
CN101961306B (zh) * 2009-07-24 2011-11-09 北京化工大学 一种低熔点药物固体分散体的制备方法
CN102144982B (zh) * 2011-03-30 2012-12-12 江苏神龙药业有限公司 一种米诺膦酸片及其制备方法
CN102406940B (zh) * 2011-11-01 2013-07-03 温州大学 一种纳米级片状羧甲基淀粉钠在固体分散体中的应用
WO2013154511A1 (fr) * 2012-04-13 2013-10-17 Mahmut Bilgic Formulations de comprimés pelliculés comprenant du dexibuprofène
UY36046A (es) 2014-03-26 2015-10-30 Millennium Pharm Inc Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
JP6647902B2 (ja) * 2015-10-30 2020-02-14 株式会社ファンケル 徐放性顆粒剤
CN106265522A (zh) * 2016-08-30 2017-01-04 铜陵翔宇商贸有限公司 布洛芬‑pvp共沉淀物及其制备方法
JP7109255B2 (ja) * 2017-05-23 2022-07-29 ライオン株式会社 粉砕物の製造方法及び錠剤の製造方法
JP7147262B2 (ja) 2017-05-23 2022-10-05 大正製薬株式会社 固形製剤
CN110621305A (zh) * 2017-07-24 2019-12-27 爱科思华制药研发有限责任公司 高载药量药物组合物
RU2685294C1 (ru) * 2018-05-10 2019-04-17 Общество с ограниченной ответственностью "ДИНОН" (ООО "ДИНОН") Поглотитель, способ его приготовления (варианты) и способ удаления диоксида углерода из газовых смесей
CN112263567B (zh) * 2020-10-19 2022-05-03 南京易亨制药有限公司 一种布洛芬缓释胶囊及制备方法
CN117363320B (zh) * 2023-12-07 2024-02-13 黑龙江省鑫博鑫交通科技有限公司 一种公路用融雪剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120616A (en) * 1980-02-27 1981-09-22 Kaken Pharmaceut Co Ltd Ibuprofen-containing granule, its preparation, and internal medicine comprising it
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CH669523A5 (fr) * 1986-06-25 1989-03-31 Mepha Ag
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
DE19509807A1 (de) * 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
IL123505A (en) * 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
BR0016236A (pt) * 1999-12-09 2002-12-24 Boots Co Plc Agentes terapêuticos
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
BRPI0619868A8 (pt) 2016-06-07
NZ569813A (en) 2011-07-29
BRPI0619868A2 (pt) 2011-10-25
CN101330904A (zh) 2008-12-24
EP1968542A1 (fr) 2008-09-17
AU2006325658B2 (en) 2010-04-08
EP1968542B1 (fr) 2013-08-14
HK1126671A1 (en) 2009-09-11
EP1968542A4 (fr) 2010-06-02
CA2633266A1 (fr) 2007-06-21
US20080292702A1 (en) 2008-11-27
CA2633266C (fr) 2011-08-02
AU2006325658A1 (en) 2007-06-21
CN101330904B (zh) 2012-04-18
NO339674B1 (no) 2017-01-23
JP2009519326A (ja) 2009-05-14
IL191804A0 (en) 2008-12-29
ES2429097T3 (es) 2013-11-13
NO20083151L (no) 2008-09-05
WO2007069874A1 (fr) 2007-06-21
RU2403013C2 (ru) 2010-11-10
RU2008129041A (ru) 2010-01-27

Similar Documents

Publication Publication Date Title
HK1126671A1 (en) Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
ZA200704163B (en) Oral medicament for the modified release of at least one active principle, in a multimicrocapsule form
IL181301A0 (en) Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
IL180887A0 (en) Quinoline derivatives and insecticide comprising thereof as active ingredient
IL177566A0 (en) Pharmaceutical formulations
PL2386294T3 (pl) Jednolita farmaceutyczna postać dawkowania fumaranu dizoproksylu tenofowiru, emtrycytabiny, efawirenzu i środka powierzchniowo czynnego
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
AP2007004247A0 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
IL188744A0 (en) High drug load formulations and dosage forms
ZA200804477B (en) Agrochemical nanoparticulate active ingredient formulations
IL174958A0 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
IL190698A0 (en) Nanoparticulate active ingredient formulations
ZA200900929B (en) Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
EP2045253A4 (fr) DÉRIVÉ D'ACIDE alpha-AMINÉ ET PRODUIT PHARMACEUTIQUE QUI LE COMPREND EN TANT QUE MATIÈRE ACTIVE
HK1115315A1 (en) Tablet containing hardly soluble active ingredient
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
HK1098962A1 (en) Antimycobacterial pharmaceutical composition comprising an antitubercular drug
EP2006287A4 (fr) Compose ayant une activite antimalarique et medicament antimalarique le contenant en tant que substance active
AU2003268386A1 (en) Controlled drug release tablets
HK1105358A1 (en) Solid pharmaceutical formulation
GB0406048D0 (en) Drug formulations
WO2006123358A3 (fr) Composition pharmaceutique orale stable
AU2007291577B2 (en) Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
GB0417042D0 (en) Stable pharmaceutical formulation